De Novo Myelodysplastic Syndrome

specific

A primary myelodysplastic syndrome that is not associated with prior radiation or chemotherapy treatment.

53

Centers

40

Active Trials

Cancer Funding

Top Centers for De Novo Myelodysplastic Syndrome(53)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
56.5
2
NCI Comprehensive
Active Research Program
56.5
3
NCI Comprehensive
Active Research Program
56.5
4
NCI Comprehensive
Active Research Program
56.5
5
NCI Comprehensive
Active Research Program
56.5
6
NCI Comprehensive
Active Research Program
56.5
7
NCI Comprehensive
Active Research Program
56.5
8
NCI Comprehensive
Active Research Program
56.5
9
NCI Comprehensive
Active Research Program
56.5
10
NCI Comprehensive
Active Research Program
56.5
11
NCI Comprehensive
Active Research Program
56.5
1256.5
13
NCI Comprehensive
Active Research Program
56.5
14
NCI Comprehensive
Active Research Program
56.5
15
NCI Comprehensive
Active Research Program
56.5
16
NCI Comprehensive
Active Research Program
56.5
17
NCI Comprehensive
Active Research Program
56.5
18
NCI Clinical
Active Research Program
56.5
19
NCI Comprehensive
Active Research Program
56.5
20
Active Research Program
56.5
21
Active Research Program
56.5
22
Active Research Program
56.5
23
NCI Comprehensive
Active Research Program
56.5
24
NCI Clinical
Active Research Program
56.5
25
NCI Comprehensive
Active Research Program
56.5
26
NCI Comprehensive
Active Research Program
56.5
27
NCI Comprehensive
Active Research Program
56.5
28
Active Research Program
56.5
29
Active Research Program
56.5
30
NCI Comprehensive
Active Research Program
56.5
31
Active Research Program
56.5
32
Active Research Program
56.5
33
NCI Basic_laboratory
Active Research Program
56.5
34
Active Research Program
56.5
35
Active Research Program
56.5
36
Active Research Program
56.5
37
Active Research Program
56.5
38
Active Research Program
56.5
39
Active Research Program
56.5
40
Active Research Program
56.5
41
NCI Comprehensive
34.0
42
NCI Comprehensive
34.0
43
NCI Comprehensive
34.0
4434.0
45
NCI Comprehensive
34.0
46
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
34.0
47
NCI Comprehensive
34.0
48
NCI Comprehensive
34.0
49
NCI Comprehensive
34.0
50
NCI Comprehensive
34.0
51
NCI Comprehensive
34.0
52
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
34.0
5334.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →